Serum Adalimumab Levels After Induction Are Associated With Long-Term Remission in Children With Inflammatory Bowel Disease.

Front Pediatr · 2021 · PMC8129012 · PMID 34017806

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

The adalimumab cutoff value for sustained remission (i.e., 13.85 μg/ml at the end of induction) significantly correlated with fecal calprotectin measured during the induction: patients not achieving the cutoff for adalimumab concentrations had significantly higher fecal calprotectin compared with others, and marginally significant results were observed for CRP ( Supplementary Figure 7 ).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.